Literature DB >> 8574840

Expression of recombinant feline tumor necrosis factor is toxic to Escherichia coli.

C M Otto1, F Niagro, X Su, C A Rawlings.   

Abstract

The tumor necrosis factor (TNF) genes from cats, horses, and pigs have all been cloned into the pFLAG-1 fusion protein expression vector (International Biotechnologies, Inc., Kodak, New Haven, Conn.). Growth curves for Escherichia coli containing the pFLAG-1 vector alone and the pFLAG-1 vector containing the TNF gene from each species were determined by visible light spectrophotometry (at 600 nm). Porcine TNF, equine TNF, and feline TNF cultures had slower doubling rates than cultures containing the pFLAG-1 vector alone. Cultures of cells transformed with feline TNF reached peak densities at 3 to 4 h and then decreased to near initial densities prior to the recovery of growth. The induction of expression with isopropyl-beta-D-thiogalactopyranoside (IPTG) arrested the growth of fresh feline TNF cultures for 6 h, which was followed by complete recovery. This inhibition occurred in two strains of E. coli (LL308 and JM101). Induced feline TNF cultures expressed the TNF-FLAG fusion protein for the first 6.5 h. Uninduced cultures expressed low levels of fusion protein. The feline TNF-pFLAG-1 vector was purified from cells expressing fusion protein and from cells with recovered growth curves. Sequencing the vector demonstrated the complete feline TNF gene and tac promoter in cells expressing the fusion protein and a deletional mutation of the tac promoter site in recovered cells. In contrast to equine and porcine TNF, the expression of recombinant feline TNF is toxic to E. coli. Alterations in protein folding and the prevention of secretion of the feline protein may explain the toxic effect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574840      PMCID: PMC170231          DOI: 10.1128/cdli.2.6.740-746.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  26 in total

1.  Mini-prep in ten minutes.

Authors:  C Zhou; Y Yang; A Y Jong
Journal:  Biotechniques       Date:  1990-02       Impact factor: 1.993

2.  A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

Authors:  T Espevik; J Nissen-Meyer
Journal:  J Immunol Methods       Date:  1986-12-04       Impact factor: 2.303

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Molecular cloning and expression in Escherichia coli of the cDNA coding for rabbit tumor necrosis factor.

Authors:  H Ito; S Yamamoto; S Kuroda; H Sakamoto; J Kajihara; T Kiyota; H Hayashi; M Kato; M Seko
Journal:  DNA       Date:  1986-04

5.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

6.  Tumor necrosis factor production in cats in response to lipopolysaccharide: an in vivo and in vitro study.

Authors:  C M Otto; C A Rawlings
Journal:  Vet Immunol Immunopathol       Date:  1995-11       Impact factor: 2.046

7.  Molecular cloning of the gene encoding rabbit tumor necrosis factor.

Authors:  H Ito; T Shirai; S Yamamoto; M Akira; S Kawahara; C W Todd; R B Wallace
Journal:  DNA       Date:  1986-04

8.  Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome.

Authors:  J Lähdevirta; C P Maury; A M Teppo; H Repo
Journal:  Am J Med       Date:  1988-09       Impact factor: 4.965

9.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance.

Authors:  B Beutler; N Krochin; I W Milsark; C Luedke; A Cerami
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

10.  Raised serum levels of tumour necrosis factor in parasitic infections.

Authors:  P Scuderi; K E Sterling; K S Lam; P R Finley; K J Ryan; C G Ray; E Petersen; D J Slymen; S E Salmon
Journal:  Lancet       Date:  1986-12-13       Impact factor: 79.321

View more
  6 in total

1.  Production of polyclonal antibodies to feline tumor necrosis factor.

Authors:  C M Otto; F Niagro; R A McGraw; C A Rawlings
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Novel, versatile, and tightly regulated expression system for Escherichia coli strains.

Authors:  Young J Choi; Lyne Morel; Teffanie Le François; Denis Bourque; Lucie Bourget; Denis Groleau; Bernard Massie; Carlos B Míguez
Journal:  Appl Environ Microbiol       Date:  2010-06-18       Impact factor: 4.792

3.  Kinetic studies of recombinant human interferon-gamma expression in continuous cultures of E. coli.

Authors:  S Thangminlal Vaiphei; Gaurav Pandey; K J Mukherjee
Journal:  J Ind Microbiol Biotechnol       Date:  2009-08-30       Impact factor: 3.346

4.  Glycine-rich RNA binding protein of Oryza sativa inhibits growth of M15 E. coli cells.

Authors:  Upasana Singh; Debadutta Deb; Amanjot Singh; Anil Grover
Journal:  BMC Res Notes       Date:  2011-01-26

Review 5.  High-throughput recombinant protein expression in Escherichia coli: current status and future perspectives.

Authors:  Baolei Jia; Che Ok Jeon
Journal:  Open Biol       Date:  2016-08       Impact factor: 6.411

Review 6.  Strategies to optimize protein expression in E. coli.

Authors:  Dana M Francis; Rebecca Page
Journal:  Curr Protoc Protein Sci       Date:  2010-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.